Industries > Pharma > North America Molecular Diagnostics Market Report 2020-2030

Back to Pharma Reports

North America Molecular Diagnostics Market Report 2020-2030

Revenue Prospects by Test (Point of Care, Self-test or Over the Counter (OTC), Central laboratories), by Product (Instruments, Reagents, Others), Technology (Polymerase Chain Reaction (Multiplex PCR, Other PCR), Chips and Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), In Situ Hybridization, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others), Application (Cardiovascular Disease, Genetic Testing (Newborn Screening, Predictive and Presymptomatic Testing, Other Genetic Testing), Infectious Diseases (Clostridium Difficile, Candida, Clostridium Difficile, Chlamydia, Flu, Gastrointestinal Panel Testing, Gonorrhea, HIV, Hepatitis B, Hepatitis C, Meningitis, Methicillin-resistant Staphylococcus Aureus, Respiratory Syncytial Virus, Tuberculosis and Drug-resistant, Others), Microbiology, Neurological Diseases, Oncology (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer, Other Cancer) Pharmacogenomics, Others) and Geography

PAGES: 199

PRODUCT CODE: PHA0617

SUBMARKET: Diagnostics

DOWNLOAD FREE SAMPLE

Licence

Clear

DOWNLOAD FREE SAMPLE

SKU: PHA0617 Categories: Diagnostics, Pharma Tags: PHA0533, PHA0617

Molecular Diagnostics– our new study reveals trends, R&D progress, and predicted revenues
Where is the Molecular Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 150+ page report provides 13 tables, 25 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Molecular Diagnostics market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the North American market and submarkets
Along with revenue prediction for the overall North American market, there are 4 segmentations of the North American Molecular Diagnostics market, with forecasts for 3 Tests, 3 Products, 7 Technologies, 8 Applications, each forecasted at a regional level.

North America Molecular Diagnostics Market by Test
– Point of Care
– Self-test or Over the Counter (OTC)
– Central laboratories

North America Molecular Diagnostics Market by Product
– Instruments
– Reagents
– Others

North America Molecular Diagnostics Market by Technology
– Polymerase Chain Reaction (PCR)
– Polymerase Chain Reaction (Multiplex PCR
– Other PCR
– Chips and microarrays
– Isothermal Nucleic Acid Amplification Technology (INAAT)
– In Situ Hybridization
– Mass Spectrometry
– Sequencing
– Transcription Mediated Amplification (TMA)
– Others

North America Molecular Diagnostics Market by Application
– Cardiovascular Disease
– Genetic Testing
– Newborn Screening
– Predictive and Presymptomatic Testing
– Other Genetic Testing
– Infectious Diseases
– Clostridium difficile
– Candida
– Clostridium difficile
– Chlamydia
– Flu
– Gastrointestinal Panel Testing
– Gonorrhea
– HIV
– Hepatitis B
– Hepatitis C
– Meningitis
– Methicillin-resistant Staphylococcus Aureus
– Respiratory Syncytial Virus
– Tuberculosis and drug-resistant
– Others
– Microbiology
– Neurological Diseases
– Oncology
– Breast Cancer
– Prostate Cancer
– Colorectal Cancer
– Cervical Cancer
– Kidney Cancer
– Liver Cancer
– Blood Cancer
– Lung Cancer
– Other Cancer
– Pharmacogenomics
– Other Applications

In addition to the revenue predictions for the overall North American market and segments, you will also find revenue forecasts for following markets:

– North America:
– U.S.
– Canada

The report also includes profiles and for some of the leading companies in the Molecular Diagnostics market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall North American revenue for Molecular Diagnostics Market will surpass $8 billion in 2025, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Molecular Diagnostics Market report helps you
In summary, our 150+ page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 4 segmentations of the Molecular Diagnostics market, with forecasts for 3 Tests, 3 Products, 7 Technologies, 8 Applications, each forecasted at a regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

– Prospects for established firms and those seeking to enter the market– including company profiles for xx of the major companies involved in the Molecular Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Molecular Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today The Molecular Diagnostics Market Forecast 2020-2030: Revenue Prospects by Test (Point of Care , Self-test or Over the Counter (OTC), Central laboratories), Product (Instruments, Reagents, Others), Technology {Polymerase Chain Reaction (Multiplex PCR, Other PCR), Chips and microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT), In Situ Hybridization, Mass Spectrometry, Sequencing, Transcription Mediated Amplification (TMA), Others}, Application {Cardiovascular Disease, Genetic Testing (Newborn Screening, Predictive and Presymptomatic Testing, Other Genetic Testing), Infectious Diseases (Clostridium difficile, Candida, Clostridium difficile, Chlamydia, Flu, Gastrointestinal Panel Testing, Gonorrhea, HIV, Hepatitis B, Hepatitis C, Meningitis, Methicillin-resistant Staphylococcus Aureus, Respiratory Syncytial Virus, Tuberculosis and drug-resistant, Others), Microbiology, Neurological Diseases, Oncology (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Blood Cancer, Lung Cancer, Other Cancer) Pharmacogenomics, Others}, and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1. Introduction

1.2. Why You Should Read This Report

1.3. Key Questions Answered by This Analytical Report

1.4. Who is This Report For?

1.5. Methodology

1.6. Frequently Asked Questions (FAQ)

1.7. Associated Visiongain Reports

1.8. About Visiongain

2. Molecular Diagnostics Market Overview

2.1. Introduction

2.1.1. Market Definition

2.1.2. Market Taxonomy

2.2. North America Molecular Diagnostics Market Size and Forecast

2.3. Market Dynamics

2.3.1. Market Drivers

2.3.1.1. Growing incidence of cancer, CVDs

2.3.1.2. Advancement in technology

2.3.1.3. Growth in next generation sequencing

2.3.1.4. Growing geriatric population

2.3.1.5. Growing demand for point of care facilities

2.3.1.6. Rising R&D investments

2.3.2. Market Restraints

2.3.2.1. Budget constraints

2.3.2.2. High initial cost

2.3.2.3. Stringent regulatory framework

2.3.3. Opportunities

2.3.3.1. Growing partnerships between diagnostic companies

2.3.3.2. Growing health awareness

2.3.4. Global Molecular Diagnostics Market: Trends

2.3.5. Mergers and Acquisitions

2.3.6. Entry of New Market Players

2.3.7. Regulatory framework

3. North America Molecular Diagnostics Market Analysis and Forecast, 2020-2030

3.1. Introduction

3.1.1. North America Molecular Diagnostics Market

3.1.2. North America Molecular Diagnostics Market, Annual Growth Rate Comparison, By Country

3.2. North America Molecular Diagnostics Market Size and Forecast, By Country

3.2.1. The U.S. Molecular Diagnostics Market

3.2.2. Canada Molecular Diagnostics Market

3.3. North America Molecular Diagnostics Market Size and Forecast, By Test

3.4. North America Molecular Diagnostics Market Size and Forecast, By Product

3.5. North America Molecular Diagnostics Market Size and Forecast, By Technology

3.6. North America Molecular Diagnostics Market Size and Forecast, By Application

3.7. North America Molecular Diagnostics Market Attractiveness Index, By Country

4. U.S. Molecular Diagnostics Market Analysis and Forecast, 2020-2030

4.1. Introduction

4.2. U.S. Molecular Diagnostics Market Size and Forecast, By Test

4.3. U.S. Molecular Diagnostics Market Size and Forecast, By Product

4.4. U.S. Molecular Diagnostics Market Size and Forecast, By Technology

4.5. U.S. Molecular Diagnostics Market Size and Forecast, By Application

5. Canada Molecular Diagnostics Market Analysis and Forecast, 2020-2030

5.1. Introduction

5.2. Canada Molecular Diagnostics Market Size and Forecast, By Test

5.3. Canada Molecular Diagnostics Market Size and Forecast, By Product

5.4. Canada Molecular Diagnostics Market Size and Forecast, By Technology

5.5. Canada Molecular Diagnostics Market Size and Forecast, By Application

6. Leading Companies in the Molecular Diagnostics Market

6.1. Competition Dashboard

6.2. Company Share Analysis

6.3. Leading Players

6.4. Abbott

6.4.1. Company Overview

6.4.2. Product Offerings

6.4.3. Financial Performance (2016-2018)

6.4.4. Recent Initiatives

6.5. Becton, Dickinson and Company

6.5.1. Company Overview

6.5.2. Product Offerings

6.5.3. Financial Performance (2016-2018)

6.5.4. Recent Initiatives

6.6. BioMérieux SA

6.6.1. Company Overview

6.6.2. Product Offerings

6.6.3. Financial Performance (2016-2018)

6.6.4. Recent Initiatives

6.7. Bio-Rad Laboratories, Inc.

6.7.1. Company Overview

6.7.2. Product Offerings

6.7.3. Financial Performance (2016-2018)

6.7.4. Recent Initiatives

6.8. Cepheid

6.8.1. Company Overview

6.8.2. Product Offerings

6.8.3. Financial Performance (2016-2018)

6.8.4. Recent Initiatives

6.9. Dako

6.9.1. Company Overview

6.9.2. Product Offerings

6.9.3. Financial Performance (2016-2018)

6.9.4. Recent Initiatives

6.10. Danaher Corporation

6.10.1. Company Overview

6.10.2. Product Offerings

6.10.3. Financial Performance (2016-2018)

6.10.4. Recent Initiatives

6.11. Foundation Medicine

6.11.1. Company Overview

6.11.2. Product Offerings

6.11.3. Financial Performance (2016-2018)

6.11.4. Recent Initiatives

6.12. Genomic Health

6.12.1. Company Overview

6.12.2. Product Offerings

6.12.3. Financial Performance (2016-2018)

6.12.4. Recent Initiatives

6.13. Hologic, Inc. (Gen Probe)

6.13.1. Company Overview

6.13.2. Product Offerings

6.13.3. Financial Performance (2016-2018)

6.13.4. Recent Initiatives

6.14. Illumina, Inc.

6.14.1. Company Overview

6.14.2. Product Offerings

6.14.3. Financial Performance (2016-2018)

6.14.4. Recent Initiatives

6.15. Johnson & Johnson Services, Inc.

6.15.1. Company Overview

6.15.2. Product Offerings

6.15.3. Financial Performance (2016-2018)

6.15.4. Recent Initiatives

6.16. Novartis (Grifols)

6.16.1. Company Overview

6.16.2. Product Offerings

6.16.3. Financial Performance (2016-2018)

6.16.4. Recent Initiatives

6.17. Qiagen

6.17.1. Company Overview

6.17.2. Product Offerings

6.17.3. Financial Performance (2016-2018)

6.17.4. Recent Initiatives

6.18. Roche Diagnostics

6.18.1. Company Overview

6.18.2. Product Offerings

6.18.3. Financial Performance (2016-2018)

6.18.4. Recent Initiatives

6.19. Siemens Healthcare Private Limited

6.19.1. Company Overview

6.19.2. Product Offerings

6.19.3. Financial Performance (2016-2018)

6.19.4. Recent Initiatives

6.20. Sysmex Corporation

6.20.1. Company Overview

6.20.2. Product Offerings

6.20.3. Financial Performance (2016-2018)

6.20.4. Recent Initiatives

7. Conclusion

8. Glossary

LIST OF TABLES

Table 1 North America: Molecular Diagnostics Market Size, By Country, 2020-2030 (USD Mn, CAGR%)

Table 2 North America: Molecular Diagnostics Market Size, By Test, 2020-2030 (USD Mn, CAGR%)

Table 3 North America: Molecular Diagnostics Market Size, By Product, 2020-2030 (USD Mn, CAGR%)

Table 4 North America: Molecular Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)

Table 5 North America: Molecular Diagnostics Market Size, By Application, 2020-2030 (USD Mn, CAGR%)

Table 6 U.S. Molecular Diagnostics Market Size, By Test, 2020-2030 (USD Mn, CAGR%)

Table 7 U.S. Molecular Diagnostics Market Size, By Product, 2020-2030 (USD Mn, CAGR%)

Table 8 U.S. Molecular Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)

Table 9 U.S. Molecular Diagnostics Market Size, By Application, 2020-2030 (USD Mn, CAGR%)

Table 10 Canada Molecular Diagnostics Market Size, By Test, 2020-2030 (USD Mn, CAGR%)

Table 11 Canada Molecular Diagnostics Market Size, By Product, 2020-2030 (USD Mn, CAGR%)

Table 12 Canada Molecular Diagnostics Market Size, By Technology, 2020-2030 (USD Mn, CAGR%)

Table 13 Canada Molecular Diagnostics Market Size, By Application, 2020-2030 (USD Mn, CAGR%)

LIST OF FIGURES

Figure 1 Molecular Diagnostics Market Segmentation

Figure 2 Drivers, Restraints, Opportunities, and Challenges in the Molecular Diagnostics Market

Figure 3 Value Chain Analysis

Figure 4 Porter’s Five Forces Analysis

Figure 5 North America Molecular Diagnostics Market Snapshot

Figure 6 U.S. Molecular Diagnostics Market, 2020-2030 (USD Mn)

Figure 7 Canada Molecular Diagnostics Market, 2020-2030 (USD Mn)

Figure 8 Company Share Analysis

Figure 9 Abbott Financial Snapshot

Figure 10 Becton, Dickinson and Company Financial Snapshot

Figure 11 BioMérieux SA Financial Snapshot

Figure 12 Bio-Rad Laboratories, Inc. Financial Snapshot

Figure 13 Cepheid Financial Snapshot

Figure 14 Dako Financial Snapshot

Figure 15 Danaher Corporation Financial Snapshot

Figure 16 Foundation Medicine Financial Snapshot

Figure 17 Genomic Health Financial Snapshot

Figure 18 Hologic, Inc. (Gen Probe) Financial Snapshot

Figure 19 Illumina, Inc. Financial Snapshot

Figure 20 Johnson & Johnson Services, Inc. Financial Snapshot

Figure 21 Novartis (Grifols) Financial Snapshot

Figure 22 Qiagen Financial Snapshot

Figure 23 Roche Diagnostics Financial Snapshot

Figure 24 Siemens Healthcare Private Limited Financial Snapshot

Figure 25 Sysmex Corporation Financial Snapshot

Download sample pages

Complete the form below to download your free sample pages for North America Molecular Diagnostics Market Report 2020-2030

Download sample pages

Complete the form below to download your free sample pages for North America Molecular Diagnostics Market Report 2020-2030

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

READ

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

READ

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

READ

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

READ

Industries > Pharma > North America Molecular Diagnostics Market Report 2020-2030

Back to Pharma Reports

North America Molecular Diagnostics Market Report 2020-2030

Download sample pages

Related reports

Microfluidics Market Report 2020-2030

Point of Care Diagnostics Market Report 2020-2030

Molecular Diagnostics Market Report 2020-2030

Paper Diagnostics Market Report 2020-2030

Microfluidics Prototype Market Report 2020-2030

Biochips Market Report 2020-2030

In-Vitro Diagnostics Quality Control Market Report 2019-2029

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

Our Clients